These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Porphyrins as urinary biomarkers for bladder cancer after 5-aminolevulinic acid (ALA) administration: the potential of photodynamic screening for tumors. Inoue K, Ota U, Ishizuka M, Kawada C, Fukuhara H, Shuin T, Okura I, Tanaka T, Ogura S. Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):484-9. PubMed ID: 24284101 [Abstract] [Full Text] [Related]
17. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer. Fukuhara H, Inoue K, Kurabayashi A, Furihata M, Fujita H, Utsumi K, Sasaki J, Shuin T. Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092 [Abstract] [Full Text] [Related]
18. Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring. Feng B, Zheng MH, Zheng YF, Lu AG, Li JW, Wang ML, Ma JJ, Xu GW, Liu BY, Zhu ZG. J Gastroenterol Hepatol; 2005 Dec; 20(12):1913-9. PubMed ID: 16336453 [Abstract] [Full Text] [Related]
19. Alu-based cell-free DNA: a potential complementary biomarker for diagnosis of colorectal cancer. Qi J, Qian C, Shi W, Wu X, Jing R, Zhang L, Wang Z, Ju S. Clin Biochem; 2013 Jan; 46(1-2):64-9. PubMed ID: 22975639 [Abstract] [Full Text] [Related]
20. Current status of photodynamic technology for urothelial cancer. Inoue K, Fukuhara H, Yamamoto S, Karashima T, Kurabayashi A, Furihata M, Hanazaki K, Lai HW, Ogura SI. Cancer Sci; 2022 Feb; 113(2):392-398. PubMed ID: 34750935 [Abstract] [Full Text] [Related] Page: [Next] [New Search]